Progyny financials
$24.79−2.86%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Quarter | Q2 '26 Jun 30 | Q1 '26 Mar 31 | Q4 '25 Dec 31 | Q3 '25 Sep 30 | Q2 '25 Jun 30 | Q1 '25 Mar 31 | Q4 '24 Dec 31 | Q3 '24 Sep 30 | Q2 '24 Jun 30 | Q1 '24 Mar 31 | Q4 '23 Dec 31 | Q3 '23 Sep 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $350.5M | $328.5M | $318.4M | $313.3M | $332.9M | $324.0M | $298.4M | $286.6M | $304.1M | $278.1M | $269.9M | $280.9M |
| Gross profit | $89.3M | $83.1M | $76.9M | $72.8M | $79.0M | $75.8M | $63.4M | $59.2M | $68.3M | $62.4M | $56.9M | $62.6M |
| Gross margin | 25.5% | 25.3% | 24.1% | 23.2% | 23.7% | 23.4% | 21.3% | 20.7% | 22.5% | 22.4% | 21.1% | 22.3% |
| Operating income | $40.0M | $35.4M | $15.2M | $21.5M | $24.4M | $24.2M | $15.8M | $12.5M | $20.7M | $18.5M | $13.8M | $18.2M |
| Net income | $28.1M | $24.2M | $12.5M | $13.9M | $17.1M | $15.1M | $10.5M | $10.4M | $16.5M | $16.9M | $13.5M | $15.9M |
| Net margin | 8.0% | 7.4% | 3.9% | 4.4% | 5.1% | 4.6% | 3.5% | 3.6% | 5.4% | 6.1% | 5.0% | 5.7% |
| Diluted EPS | $0.34 | $0.29 | $0.14 | $0.15 | $0.19 | $0.17 | $0.12 | $0.11 | $0.17 | $0.17 | $0.13 | $0.16 |
| EBITDA | $41.6M | $36.9M | $16.6M | $21.5M | $25.6M | $25.3M | $16.7M | $12.5M | $20.7M | $18.5M | $13.8M | $16.1M |
| Operating cash flow | $50.4M | $45.9M | $54.2M | $50.7M | $55.5M | $49.8M | $52.2M | $44.5M | $56.7M | $25.7M | $37.7M | $54.2M |
| Free cash flow | $44.2M | $39.6M | $48.6M | $46.0M | $50.2M | $47.0M | $50.3M | $42.7M | $55.8M | $24.9M | $37.0M | $53.2M |
| Diluted shares | 82.1M | 84.8M | 89.5M | 90.2M | 89.6M | 89.3M | 88.9M | 93.8M | 97.8M | 101.1M | 101.0M | 100.9M |
Balance sheet
| Period end | Jun 30 | Mar 31 | Dec 31 | Sep 30 | Jun 30 | Mar 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $152.6M | $131.6M | $112.2M | $134.0M | $132.5M | $109.2M |
| Short-term investments | $84.3M | $93.5M | $197.9M | $211.2M | $172.6M | $146.9M |
| Total debt | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total assets | $715.8M | $698.3M | $742.4M | $795.2M | $761.0M | $730.3M |
| Total liabilities | $262.6M | $259.0M | $226.4M | $235.2M | $245.9M | $263.1M |
| Shareholders' equity | $453.3M | $439.3M | $516.0M | $560.0M | $515.0M | $467.2M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology